Carolinas Wealth Consulting LLC Bio Techne Corp Transaction History

Carolinas Wealth Consulting LLC

$577 Million
Q3 2024

A detailed history of Carolinas Wealth Consulting LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Carolinas Wealth Consulting LLC holds 29 shares of TECH stock, worth $2,121. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 26 11.54%

Holding current value

$2,121

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$70.96 - $82.35 $212 - $247	3 Added 11.54%	29 $2,000
Q2 2024 Aug 12, 2024	BUY	$62.12 - $84.15 $745 - $1,009	12 Added 85.71%	26 $1,000
Q1 2024 May 14, 2024	BUY	$65.98 - $77.09 $923 - $1,079	14 New	14 $0
Q1 2023 May 15, 2023	SELL	$71.62 - $86.62 $47,555 - $57,515	-664 Reduced 95.95%	28 $2,000
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $44,691 - $195,168	554 Added 401.45%	692 $57,000
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $3,390 - $4,702	-12 Reduced 8.0%	138 $39,000
Q2 2022 Aug 16, 2022	BUY	$322.67 - $449.65 $6,776 - $9,442	21 Added 16.28%	150 $52,000
Q1 2022 May 17, 2022	BUY	$353.85 - $487.79 $1,061 - $1,463	3 Added 2.38%	129 $56,000
Q4 2021 Feb 14, 2022	BUY	$456.15 - $525.06 $35,579 - $40,954	78 Added 162.5%	126 $65,000
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $3,558 - $4,311	-8 Reduced 14.29%	48 $23,000
Q2 2021 Aug 17, 2021	SELL	$387.35 - $450.26 $387 - $450	-1 Reduced 1.75%	56 $25,000
Q1 2021 May 17, 2021	BUY	$314.62 - $411.0 $17,933 - $23,427	57 New	57 $22,000

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Carolinas Wealth Consulting LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carolinas Wealth Consulting LLC with notifications on news.

Account

Carolinas Wealth Consulting LLC Bio Techne Corp Transaction History